Literature DB >> 15726997

Industry, innovation and social values.

Harvey E Bale1.   

Abstract

Remaining important tasks in finding and developing new drugs and vaccines for HIV/AIDS, malaria, cancer and other diseases require continued industry research and development. Industry's research and development pipeline has produced drugs that have saved AIDS victims previously facing certain death, but still no cure nor vaccine is yet available. Experience with the process of research and development indicates that it requires more than a decade of development to produce a new drug with costs in the hundreds of millions of dollars. Intellectual property protection is critically important in assuring that drug development continues. Partnerships between industry and the public sector have increased access to new therapies in developing countries and promise to enhance access to both patented and generic medicines in the future.

Entities:  

Keywords:  Health Care and Public Health

Mesh:

Year:  2005        PMID: 15726997      PMCID: PMC7089058          DOI: 10.1007/s11948-005-0053-9

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  13 in total

1.  Global public-private partnerships: Part I--A new development in health?

Authors:  K Buse; G Walt
Journal:  Bull World Health Organ       Date:  2000       Impact factor: 9.408

Review 2.  Medical need, scientific opportunity and the drive for antimalarial drugs.

Authors:  Robert G Ridley
Journal:  Nature       Date:  2002-02-07       Impact factor: 49.962

Review 3.  Progress in HIV vaccine development.

Authors:  M I Johnston; J Flores
Journal:  Curr Opin Pharmacol       Date:  2001-10       Impact factor: 5.547

4.  Antibiotic resistance--the interplay between antibiotic use in animals and human beings.

Authors:  Randall S Singer; Roger Finch; Henrik C Wegener; Robin Bywater; John Walters; Marc Lipsitch
Journal:  Lancet Infect Dis       Date:  2003-01       Impact factor: 25.071

5.  AIDS epidemic update: December 1999.

Authors: 
Journal:  AIDS Anal Afr       Date:  2000 Feb-Mar

6.  How do patents and economic policies affect access to essential medicines in developing countries?

Authors:  Amir Attaran
Journal:  Health Aff (Millwood)       Date:  2004 May-Jun       Impact factor: 6.301

7.  The corporate social responsibility of the pharmaceutical industry: idealism without illusion and realism without resignation.

Authors:  Klaus M Leisinger
Journal:  Bus Ethics Q       Date:  2005-10

Review 8.  The pneumococcal problem.

Authors:  S K Obaro; M A Monteil; D C Henderson
Journal:  BMJ       Date:  1996-06-15

9.  Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

Authors:  Kholoud Porter; Abdel Babiker; Krishnan Bhaskaran; Janet Darbyshire; Patrizio Pezzotti; Kholoud Porter; A Sarah Walker
Journal:  Lancet       Date:  2003-10-18       Impact factor: 79.321

10.  Emerging infections: getting ahead of the curve.

Authors:  D Satcher
Journal:  Emerg Infect Dis       Date:  1995 Jan-Mar       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.